Welcome to Join Our First GenovisWebinar!

November 8, 2022 | GenovisWebinars, News |

We are excited to announce our series of GenovisWebinars, and we are happy to invite you to the first webinar held on November 17th!
Each webinar will showcase inspirational SmartEnzymes user, and the topics discussed are influenced by how to improve analytical workflows. Please join us in sharing experiences!

​​​Genovis SmartEnzymes are powerful tools in the characterization of biopharmaceuticals, particularly when used in combination with techniques such as LC-MS.
We are delighted to welcome Esther Martin from AstraZeneca as our first speaker, to talk about her experiences using Genovis SmartEnzymes. Register now and learn about how Esther and her team have improved the analytical characterization workflows using GlySERIAS™ and other SmartEnzymes!
Title: Improved Characterization of Complex Biopharmaceuticals using SmartEnzymes™ Subunit Workflows
Date: November 17th, 2022
Time: 4 pm CET

Key Learning Objectives

  • The importance of sample preparation and advantages of middle-level analysis
  • Use of SmartEnzymes for the characterization of biopharmaceuticals
  • Addressing the challenges of middle-level analysis of new modalities, such as complex fusion proteins

Who Should Attend?

  • Scientists involved in the MS characterization of biopharmaceuticals
  • UScientists involved in the analysis of: GS- or polyglycine-linked fusion proteins, monoclonal antibodies, bispecific antibodies and glycosylated molecules
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)



GlySERIAS is a unique enzyme that digests flexible glycine-rich fusion protein linkers such as Gly4Ser and GlyxSery (GS) and polyglycine (G) linkers.
The enzyme enables separation of the individual domains of multi-functional fusion proteins to facilitate characterization and increase the understanding of these molecules. Middle-level analysis of fusion proteins serves to both reduce the overall sample complexity and allow for domain-specific identification and monitoring of post-translational modifications.​​
Learn More About GlySERIAS